Dipesh S. Harmalkar

629 total citations
18 papers, 473 citations indexed

About

Dipesh S. Harmalkar is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Dipesh S. Harmalkar has authored 18 papers receiving a total of 473 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 5 papers in Organic Chemistry and 5 papers in Biochemistry. Recurrent topics in Dipesh S. Harmalkar's work include Natural product bioactivities and synthesis (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Dipesh S. Harmalkar is often cited by papers focused on Natural product bioactivities and synthesis (6 papers), Cancer, Hypoxia, and Metabolism (4 papers) and Traditional and Medicinal Uses of Annonaceae (4 papers). Dipesh S. Harmalkar collaborates with scholars based in South Korea, China and Japan. Dipesh S. Harmalkar's co-authors include Kyeong Lee, Xuezhen Xu, Ravi Naik, Yongseok Choi, Hyun Seung Ban, Misun Won, Bo‐Kyung Kim, Miso Nam, Hwan Mook Kim and Song‐Kyu Park and has published in prestigious journals such as Scientific Reports, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Dipesh S. Harmalkar

17 papers receiving 466 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dipesh S. Harmalkar South Korea 11 222 168 83 65 40 18 473
Xuezhen Xu South Korea 7 153 0.7× 187 1.1× 115 1.4× 54 0.8× 49 1.2× 14 443
Ravi Naik South Korea 11 190 0.9× 264 1.6× 137 1.7× 60 0.9× 54 1.4× 20 529
Fenghua Kang China 13 138 0.6× 308 1.8× 68 0.8× 118 1.8× 72 1.8× 35 547
Min‐Tsang Hsieh Taiwan 14 234 1.1× 207 1.2× 35 0.4× 64 1.0× 31 0.8× 45 505
Chiara Giommarelli Italy 8 207 0.9× 233 1.4× 49 0.6× 102 1.6× 48 1.2× 8 566
Asif Khurshid Qazi India 16 137 0.6× 319 1.9× 61 0.7× 61 0.9× 45 1.1× 20 527
Mubashir J. Mintoo India 17 173 0.8× 354 2.1× 64 0.8× 64 1.0× 88 2.2× 25 698
Hong‐Gui Xu China 11 141 0.6× 284 1.7× 63 0.8× 45 0.7× 50 1.3× 47 573
Wenda Zhang China 15 156 0.7× 295 1.8× 80 1.0× 38 0.6× 151 3.8× 23 555
Chong−Wen Bi China 13 115 0.5× 316 1.9× 79 1.0× 138 2.1× 81 2.0× 35 588

Countries citing papers authored by Dipesh S. Harmalkar

Since Specialization
Citations

This map shows the geographic impact of Dipesh S. Harmalkar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dipesh S. Harmalkar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dipesh S. Harmalkar more than expected).

Fields of papers citing papers by Dipesh S. Harmalkar

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dipesh S. Harmalkar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dipesh S. Harmalkar. The network helps show where Dipesh S. Harmalkar may publish in the future.

Co-authorship network of co-authors of Dipesh S. Harmalkar

This figure shows the co-authorship network connecting the top 25 collaborators of Dipesh S. Harmalkar. A scholar is included among the top collaborators of Dipesh S. Harmalkar based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dipesh S. Harmalkar. Dipesh S. Harmalkar is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Harmalkar, Dipesh S., et al.. (2024). Natural products as IL‐6 inhibitors for inflammatory diseases: Synthetic and SAR perspective. Medicinal Research Reviews. 44(4). 1683–1726. 13 indexed citations
2.
Han, Tae-Hee, Joohan Lee, Dipesh S. Harmalkar, et al.. (2024). Stilbenoid derivatives as potent inhibitors of HIF-1α-centric cancer metabolism under hypoxia. Biomedicine & Pharmacotherapy. 176. 116838–116838. 3 indexed citations
3.
Harmalkar, Dipesh S., Chang‐Hoon Lee, Jae Geun Song, et al.. (2023). Discovery of a novel BLT2 antagonist for the treatment of inflammatory airway diseases. European Journal of Medicinal Chemistry. 261. 115864–115864. 1 indexed citations
4.
Harmalkar, Dipesh S., et al.. (2021). Total Synthesis of the Neuroprotective Agent Cudraisoflavone J. Journal of Natural Products. 84(4). 1359–1365. 7 indexed citations
5.
Kwon, Ok‐Kyoung, Jae‐Won Lee, Xuezhen Xu, et al.. (2020). DK-1108 exerts anti-inflammatory activity against phorbol 12-myristate 13-acetate-induced inflammation and protective effect against OVA-induced allergic asthma. Biomedicine & Pharmacotherapy. 132. 110950–110950. 11 indexed citations
6.
Harmalkar, Dipesh S., et al.. (2020). Elucidation of Mechanism for Ligand Efficacy at Leukotriene B4 Receptor 2 (BLT2). ACS Medicinal Chemistry Letters. 11(8). 1529–1534. 8 indexed citations
7.
Kim, Jin Sook, Dipesh S. Harmalkar, Joong‐Won Park, et al.. (2020). Synthesis and Cytotoxicity Studies of Bioactive Benzofurans from Lavandula agustifolia and Modified Synthesis of Ailanthoidol, Homoegonol, and Egonol. Journal of Natural Products. 83(11). 3354–3362. 10 indexed citations
8.
Harmalkar, Dipesh S., et al.. (2019). A protecting group-free divergent synthesis of natural benzofurans via one-pot synthesis of 2-bromo-6-hydroxybenzofurans. Organic & Biomolecular Chemistry. 17(8). 2153–2161. 14 indexed citations
9.
Harmalkar, Dipesh S., et al.. (2019). Identification of novel non-nucleoside vinyl-stilbene analogs as potent norovirus replication inhibitors with a potential host-targeting mechanism. European Journal of Medicinal Chemistry. 184. 111733–111733. 10 indexed citations
10.
Harmalkar, Dipesh S., et al.. (2019). An Overview of Saturated Cyclic Ethers: Biological Profiles and Synthetic Strategies. Molecules. 24(20). 3778–3778. 59 indexed citations
11.
Xu, Xuezhen, Ok‐Kyoung Kwon, In‐Sik Shin, et al.. (2019). Novel benzofuran derivative DK-1014 attenuates lung inflammation via blocking of MAPK/AP-1 and AKT/mTOR signaling in vitro and in vivo. Scientific Reports. 9(1). 862–862. 13 indexed citations
12.
Harmalkar, Dipesh S., et al.. (2018). Schweinfurthins A–Q: isolation, synthesis, and biochemical properties. RSC Advances. 8(38). 21191–21209. 12 indexed citations
13.
Harmalkar, Dipesh S., et al.. (2018). Total Synthesis of Gramistilbenoids A, B, and C. Journal of Natural Products. 81(4). 798–805. 7 indexed citations
14.
Singh, Sarbjit, Dipesh S. Harmalkar, Yongseok Choi, & Kyeong Lee. (2018). Fructose-1,6-bisphosphatase Inhibitors: A Review of Recent (2000- 2017) Advances and Structure-Activity Relationship Studies. Current Medicinal Chemistry. 26(29). 5542–5563.
15.
Ban, Hyun Seung, Bo‐Kyung Kim, Hwan Mook Kim, et al.. (2017). The novel hypoxia-inducible factor-1α inhibitor IDF-11774 regulates cancer metabolism, thereby suppressing tumor growth. Cell Death and Disease. 8(6). e2843–e2843. 70 indexed citations
16.
Naik, Ravi, Hyun Seung Ban, Xuezhen Xu, et al.. (2017). Methyl 3-(3-(4-(2,4,4-Trimethylpentan-2-yl)phenoxy)-propanamido)benzoate as a Novel and Dual Malate Dehydrogenase (MDH) 1/2 Inhibitor Targeting Cancer Metabolism. Journal of Medicinal Chemistry. 60(20). 8631–8646. 29 indexed citations
17.
Naik, Ravi, et al.. (2015). ChemInform Abstract: Bioactive Benzofuran Derivatives: Moracins A—Z in Medicinal Chemistry. ChemInform. 46(8). 1 indexed citations
18.
Naik, Ravi, et al.. (2014). Bioactive benzofuran derivatives: Moracins A–Z in medicinal chemistry. European Journal of Medicinal Chemistry. 90. 379–393. 205 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xuezhen Xu Breakdown of academic impact, for papers by Ravi Naik Breakdown of academic impact, for papers by Fenghua Kang Breakdown of academic impact, for papers by Min‐Tsang Hsieh Breakdown of academic impact, for papers by Chiara Giommarelli Breakdown of academic impact, for papers by Asif Khurshid Qazi Breakdown of academic impact, for papers by Mubashir J. Mintoo Breakdown of academic impact, for papers by Hong‐Gui Xu Breakdown of academic impact, for papers by Wenda Zhang Breakdown of academic impact, for papers by Chong−Wen Bi
Rankless by CCL
2026